CPB2

Carboxypeptidase B2 · Q96IY4 · CPB2 on Sugi Atlas →

38,487 patent compounds predicted against CPB2, 17,226 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL454654 SCHEMBL454654 0.50 15/20
SCHEMBL364062 SCHEMBL364062 0.50 13/20
SCHEMBL364063 SCHEMBL364063 0.50 13/20
SCHEMBL516843 SCHEMBL516843 0.32 13/20
SCHEMBL589342 SCHEMBL589342 0.49 12/20
SCHEMBL209237 SCHEMBL209237 0.45 12/20
SCHEMBL43995 SCHEMBL43995 0.46 11/20
SCHEMBL43996 SCHEMBL43996 0.46 11/20
SCHEMBL574662 SCHEMBL574662 0.44 11/20
SCHEMBL574664 SCHEMBL574664 0.44 11/20
Lysine Lysine (SCHEMBL237658) 0.44 11/20
Lysine Lysine (SCHEMBL237659) 0.44 11/20
SCHEMBL515443 SCHEMBL515443 0.39 11/20
SCHEMBL805198 SCHEMBL805198 0.45 10/20
SCHEMBL421252 SCHEMBL421252 0.45 10/20
SCHEMBL45765 SCHEMBL45765 0.43 10/20
SCHEMBL214641 SCHEMBL214641 0.43 10/20
Acetic Acid Acetic Acid (SCHEMBL268740) 0.42 10/20
SCHEMBL686694 SCHEMBL686694 0.42 10/20
SCHEMBL296013 SCHEMBL296013 0.41 10/20

Clinical trials — most relevant to CPB2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery PHASE4COMPLETED
Bradykinin Receptor Antagonism During Cardiopulmonary Bypass PHASE2/PHASE3COMPLETED
Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery PHASE1/PHASE2UNKNOWN
A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis PHASE1/PHASE2COMPLETED
Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications PHASE1UNKNOWN
Heparin Responses in Pediatric Patients Undergoing Cardiopulmonary Bypass. nanCOMPLETED
Precision Medicine in the CICU: Identifying Proteomic Biomarkers nanENROLLING_BY_INVITATION
Preventing Acute Chest Syndrome by Transfusion Feasibility Study nanCOMPLETED
Clinical Assessment of Thrombosis in Children After Heart Surgery nanCOMPLETED
Urine and Serum Biomarkers for Early Detection of Acute Kidney Injury nanCOMPLETED
Evaluation of AKI by Measuring the NephroCheck Test After Pediatric Cardiac Surgery nanUNKNOWN
Markers in Acute Pancreatitis-1 nanCOMPLETED
Evaluation of Plasma Renin Concentrations in Cardiac Surgery nanRECRUITING
Acute Pancreatitis Targets (APT) Study nanCOMPLETED
Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis nanUNKNOWN
Osteopontin Gene Polymorphism in Stroke Patients in Egypt nanNOT_YET_RECRUITING
Aprotinin Use and Renal Outcome in Hypothermic Bypass and Circulatory Arrest for Surgical Repair of Thoracic Aorta. nanCOMPLETED
Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD) nanCOMPLETED
sPLA2 in EBC During Acute Chest Syndrome nanCOMPLETED
The Prospective Risk Factor Evaluation & Discovery In CTEPH Study nanUNKNOWN
Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients nanRECRUITING
Disorders of the Acute Phase Response Following Trauma and Invasive Surgery nanENROLLING_BY_INVITATION
Catalytic Antibodies to Predict Uninvasively Late Transplant Failure nanCOMPLETED
Delirium in Elderly Undergoing Cardiac Surgery and the Significance of CholinEsterase Activity nanCOMPLETED
Presepsin as a Predictor for Postoperative Complications Following Pancreatic Resection nanCOMPLETED
Progression of Early Subclinical Atherosclerosis nanACTIVE_NOT_RECRUITING
Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT) nanCOMPLETED
Bypass Clear Priming VSD Cardiopulmonary Bypass Circuit Reduce Bypass Associated Inflammation? nanNOT_YET_RECRUITING
Inflammation Markers Over Time in Cardiovascular Disease nanCOMPLETED
The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CPB2 binder may also engage these)

ProteinNameSimilarity
Q9EQV9 1.000 Q9EQV9 →
Q9JHH6 1.000 Q9JHH6 →
Q2KIG3 0.998 Q2KIG3 →
Q8WXQ8 0.996 Q8WXQ8 →
CPA4 Carboxypeptidase A4 0.989 landscape →
CPB1 Carboxypeptidase B 0.989 landscape →
CPA3 Mast cell carboxypeptidase A 0.989 landscape →
P19223 0.988 P19223 →
CPA2 Carboxypeptidase A2 0.988 landscape →
P21961 0.988 P21961 →
P15089 0.988 P15089 →
P00732 0.988 P00732 →
P09955 0.987 P09955 →
P42787 0.987 P42787 →
Q4R7R2 0.987 Q4R7R2 →
Q8R4H4 0.987 Q8R4H4 →
Q0II73 0.986 Q0II73 →
Q6P8K8 0.986 Q6P8K8 →
P55261 0.986 P55261 →
B8JLQ9 0.985 B8JLQ9 →
P00730 0.985 P00730 →
P38836 0.984 P38836 →
Q8IVL8 0.984 Q8IVL8 →
P37892 0.983 P37892 →
P09954 0.983 P09954 →
A0A1S4F020 0.983 A0A1S4F020 →
P00731 0.982 P00731 →
Q504N0 0.981 Q504N0 →
CPA1 Carboxypeptidase A1 0.980 landscape →
Q7TPZ8 0.980 Q7TPZ8 →